Home/Vivoryon Therapeutics/Frank Weber, MD

FW

Frank Weber, MD

Chief Executive Officer / Chief Medical Officer, Executive Director

Vivoryon Therapeutics

Therapeutic Areas

Renal Diseases Fibrotic Disorders Inflammatory Diseases

Vivoryon Therapeutics Pipeline

Drug	Indication	Phase
varoglutamstat	Diabetic Kidney Disease	Phase 2

Leadership Team at Vivoryon Therapeutics

Chief Financial Officer

View full Vivoryon Therapeutics profile